Longshen Rongfa
Stage
IPO | IPOTotal Raised
$16.08MDate of IPO
9/13/2016About Longshen Rongfa
Manufacturer of traditional Chinese medicine products. The company provides pills, tablets, and capsules. Its lead product is a pure Chinese drug to treat chronic pain.
Longshen Rongfa Headquarter Location
Heping Industrial Development Park
Lanzhou, Gansu, 730101,
China
86 931 5272528
Expert Collections containing Longshen Rongfa
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Longshen Rongfa is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Where is Longshen Rongfa's headquarters?
Longshen Rongfa's headquarters is located at Heping Industrial Development Park, Lanzhou.
What is Longshen Rongfa's latest funding round?
Longshen Rongfa's latest funding round is IPO.
How much did Longshen Rongfa raise?
Longshen Rongfa raised a total of $16.08M.
Who are the investors of Longshen Rongfa?
Investors of Longshen Rongfa include Dongzheng Rongtong, General Technology Venture Capital, Gansu Biotech Industry Venture Capital Fund and Guotou Transfar.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.